Dietary isoflavones and bone mineral density during midlife and the menopausal transition: Cross-sectional and longitudinal results from the Study of Women's Health Across the Nation Phytoestrogen Study

Menopause

Volumn 22, Issue 3, 2015, Pages 279-288

  Greendale, Gail A ^a   Tseng, Chi Hong ^a   Han, Weijuan ^a   Huang, Mei Hua ^a   Leung, Katherine ^b   Crawford, Sybil ^b   Gold, Ellen B ^c   Waetjen, L Elaine ^d   Karlamangla, Arun S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone density; Cohort study; Isoflavones; Menopausal transition

Indexed keywords

ISOFLAVONE DERIVATIVE;

ADULT; ARTICLE; BLACK PERSON; BONE DENSITY; CAUCASIAN; CHINESE; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; FEMUR NECK; HUMAN; JAPANESE (PEOPLE); LONGITUDINAL STUDY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; ASIAN AMERICAN; CALORIC INTAKE; CHINA; DRUG EFFECTS; ETHNOLOGY; FEMORAL NECK; JAPAN; LUMBAR VERTEBRA; MENSTRUATION; MIDDLE AGED; POSTMENOPAUSE OSTEOPOROSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN AMERICANS; BONE DENSITY; CHINA; CROSS-SECTIONAL STUDIES; ENERGY INTAKE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FEMUR NECK; HUMANS; ISOFLAVONES; JAPAN; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MENSTRUATION; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PERIMENOPAUSE; UNITED STATES;

EID: 84924496403     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000305     Document Type: Article

References (44)

1. Adlercreutz H, Heinonen SM, Penalvo-Garcia J. Phytoestrogens, cancer and coronary heart disease. Biofactors 2004;22:229-236.
2. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004;65:995-1016.
3. Magee PJ, Rowland IR. Phytoestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004;91:513-531.
4. Mortensen A, Kulling SE, Schwartz H, et al. Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res 2009;53(suppl 2):S266-S309.
5. Sharan K, Siddiqui JA, Swarnkar G, Maurya R, Chattopadhyay N. Role of phytochemicals in the prevention of menopausal bone loss: evidence from in vitro and in vivo, human interventional and pharma-cokinetic studies. Curr Med Chem 2009;16:1138-1157.
6. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor A. Endocrinology 1998;139:4252-4263.
7. Takeuchi S, Takahashi T, Sawada Y, Lida M, Matuda T, Kojima H. Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol Pharm Bull 2009;32:195-202.
8. Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphat Res Biol 2010;8:89-98.
9. Pilxáková L, Rieansk] I, Jagla F. The physiological actions of isoflavone phytoestrogens. Physiol Res 2010;59:651-664.
10. Turner JV, Agatonovic-Kustrin S, Glass BD. Molecular aspects of phytoestrogen selective binding at estrogen receptors. J Pharm Sci 2007;96: 1879-1885.
11. Banfi G, Iorio EL, Corsi MM. Oxidative stress, free radicals and bone remodeling. Clin Chem Lab Med 2008;46:1550-1555.
12. Wimalawansa SJ. Nitric oxide and bone. Ann N Y Acad Sci 2010;1192: 391-403.
13. The North American Menopause Society. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/ Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). Menopause 2011;18:732-753.
14. Taku K, Melby MK, Takebayashi J, et al. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: metaanalysis of randomized controlled trial. Asia Pac J Clin Nutr 2010;19:33-42.
15. Wong WW, Lewis RD, Steinberg FM, et al. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial. Am J Clin Nutr 2009;90:1433-1439.
16. Alekel DL, Van Loan MD, Koehler KJ, et al. The Soy Isoflavones for Reducing Bone Loss (SIRBL) study: a 3-y randomized controlled trial in post menopausal women. Am J Clin Nutr 2010;91:218-230.
17. Vupadhyayula PM, Gallagher JC, Templin T, Logsdon SM, Smith LM. Effects of soy protein isolate on bone mineral density and physical performance indices in postmenopausal womenVa 2-year randomized, double-blind, placebo-controlled trial. Menopause 2009;16:320-328.
18. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J. Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med 2011;171:1363-1369.
19. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 2001;86:5217-5221.
20. Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001;97:109-115.
21. Greendale GA, Fitzgerald G, Huang MH, et al. Dietary soy isoflavones and bone mineral density: results from the Study of Women's Health Across the Nation. Am J Epidemiol 2002;155:746-754.
22. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in post menopausal Japanese women. Osteoporos Int 2002;13:200-204.
23. Guthrie JR, Ball M, Murkies A, Dennerstein L. Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 2000;3:254-261.
24. Zhang X, Shu XO, Li H, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med 2005;165:1890-1895.
25. Koh WP, Wu AH, Wang R, et al. Gender-specific associations between soy and risk of hip fracture in the Singapore Chinese Health Study. Am J Epidemiol 2009;170:901-909.
26. Sowers MF, Crawford SL, Sternfeld B, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, eds. Menopause Biology and Pathobiology. San Diego, CA: Academic Press; 2000:175-188.
27. Huang MH, Norris J, Han W, et al. Development of an updated phytoestrogen database for use with the SWAN Food Frequency Questionnaire: intakes and food sources in a community-based, multiethnic cohort study. Nutr Cancer 2012;64:228-244.
28. Greendale GA, Sowers M, Han W, et al. Bone mineral density loss in relation to the final menstrual period in a multi-ethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res 2012;27:111-118.
29. Reinli K, Block G. Phytoestrogen content of foodsVa compendium of literature values. Nutr Cancer 1996;26:123-148.
30. Huang MH, Schocken M, Block G, et al. Variation in nutrient intakes by ethnicity: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2002;9:309-319.
31. Block G, Norris JC, Mandel RM, DiSogra C. Sources of energy and six nutrients in diets of low-income Hispanic-American women and children: quantitative data from the HHANES survey, 1982-1984. J Am Diet Assoc 1995;95:195-208.
32. Beydoun MA, Lhotsky A, Wang Y, et al. Association of adiposity status and changes in early to mid-Adulthood with incidence of Alzheimer's disease. Am J Epidemiol 2008;168:1179-1189.
33. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis. New York, NY: John Wiley; 2004.
34. Lipsitz SR, Leong T, Ibrahim J, Lipshultz S. A partial correlation coefficient and coefficient of determination for multivariate normal repeated measures data. Statistician 2001;50(pt 1):87-95.
35. Randolph JF Jr, Zheng H, Sowers MR, et al. Change in folliclestimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011;96:746-754.
36. Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 2001;16:1363-1369.
37. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE. Assessing phytoestrogen exposure in epidemiologic studies: development of a database. Cancer Causes Control 2000;11:289-298.
38. Ritchie MR, Cummings JH, Morton MS, Michael Steel C, Bolton-Smith C, Riches AC. A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intake. Br J Nutr 2006;95: 204-213.
39. Izumi T, Piskula MK, Osawa S, et al. Soy isoflavone aglycones are absorbed faster and in higher amounts then their glucosides in humans. J Nutr 2000;130:1695-1699.
40. Akaza H, Miyanaga N, Takashima N, et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol 2004;34:86-89.
41. Song KB, Atkinson C, Frankenfeld CL, et al. Prevalence of daidzeinmetabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 2006;136:1347-1351.
42. Maskarinec G, Yamakwa R, Hebshi S, Franke AA. Urinary isoflavonoid excretion and soy consumption in three generations of Japanese women in Hawaii. Eur J Clin Nutr 2007;61:255-261.
43. Recker R, Lappe J, Davies K, Heaney R. Characterization of the perimenopausal bone loss: a prospective study. J Bone Miner Res 2000; 15:1965-1973.
44. Sowers MR, Zheng H, Jannausch ML, et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. J Clin Endocrinol Metab 2010; 95:2155-2162.